Key Points
- Use the highest‑yield diagnostic test early; do not let testing delay time‑critical therapy.
- Set objective targets (hemodynamic, neurologic, respiratory) and reassess frequently.
- Plan definitive source control or reperfusion when indicated; document follow‑up and patient education.
Algorithm
- Assess perfusion/congestion; oxygen, nitrates, and noninvasive ventilation for acute pulmonary edema.
- Give IV loop diuretic (1–2× home dose); monitor urine output and spot diuretic response.
- Add vasodilators if hypertensive; escalate to inotropes if cold/hypoperfused.
- Consider sequential nephron blockade or ultrafiltration for diuretic resistance.
- Optimize chronic GDMT prior to discharge; arrange close follow-up.
Clinical Synopsis & Reasoning
Identify perfusion/congestion profile (wet/dry; warm/cold). Use IV loop diuretics (1–2× home dose), consider vasodilators in hypertensive pulmonary edema, and escalate to inotropes/ultrafiltration for diuretic resistance and hypoperfusion.
Treatment Strategy & Disposition
Stabilize ABCs. Initiate guideline‑concordant first‑line therapy with precise dosing and continuous monitoring. Escalate to advanced or procedural interventions based on explicit failure criteria. Define ICU, step‑down, and ward disposition triggers; involve specialty teams early.
Epidemiology / Risk Factors
- Risk varies by comorbidity and precipitants; see citations for condition‑specific data.
Investigations
| Test | Role / Rationale | Typical Findings | Notes |
|---|---|---|---|
| BNP/NT-proBNP | Support diagnosis | Elevated | Trend limited utility acutely |
| CXR/POCUS | Pulmonary edema/IVC | Interstitial edema, B-lines | Guide volume |
| BMP, Mg | Renal/electrolyte status | AKI, hypoK/Mg | Monitor during diuresis |
Pharmacology
| Medication/Intervention | Mechanism | Onset | Role in Therapy | Limitations |
|---|---|---|---|---|
| Furosemide IV 40–80 mg (or 1–2× home dose) | Loop diuretic | Hours | Decongestion | Monitor urine output/renal |
| Nitroglycerin infusion | Venodilator | Minutes | Hypertensive pulmonary edema | Headache/hypotension |
| Nitroprusside (selected) | Balanced vasodilator | Immediate | Severe afterload excess | Toxicity risks |
| Dobutamine/Milrinone | Inotropes | Minutes | Low-output states | Arrhythmia/hypotension |
Prognosis / Complications
- Outcome depends on timeliness of diagnosis and definitive therapy; monitor for complications.
Patient Education / Counseling
- Provide red‑flag education, adherence guidance, and explicit return precautions; arrange timely specialty follow‑up.
References
- 2022 AHA/ACC/HFSA Heart Failure Guideline — Link
Meet MDSteps: Smarter USMLE® Prep
MDSteps streamlines your study with an adaptive QBank (19,000+ high-yield MCQs across all 3 Steps), full CCS case simulations for Step 3 with live vitals and timed orders, and an exam-readiness dashboard that turns practice into insight. Build mastery by system and discipline, auto-create missed-item decks (Anki-exportable), and keep momentum with pacing guidance, trend lines, and suggested next sessions—so every block moves you closer to test-day confidence.
Compared with staples like UWorld and AMBOSS, MDSteps aims to give you the best of both worlds: exam-style practice that adapts to you, plus real-time analytics and a full CCS runner—all in one place. If you want targeted, exam-relevant reps with feedback that actually changes how you study, MDSteps is built for you.
Eplore MDSteps